Bereich
Muskelzentrum | ALS Clinic
MUSKEL · Dept. III
Neue Therapieoptionen der spinalen Muskelatrophie
Neuwirth C. Neue Therapieoptionen der spinalen Muskelatrophie - Herausforderungen der neuen krankheitsmodifizierenden Therapiemöglichkeiten. MagBrain 2021; 5-21:43-47.
18.09.2021Neue Therapieoptionen der spinalen Muskelatrophie
18.09.2021MagBrain 2021; 5-21:43-47
Neuwirth Christoph
[A several-week history of inflammatory changes in the right foot and right hand of a 57-year-old male patient]
von Lucadou M, Strahm C, Potz S, Toepfer A, Weber M, Passavanti Z, Neumann T. [A several-week history of inflammatory changes in the right foot and right hand of a 57-year-old male patient]. Internist (Berl) 2021; 62:555-561.
18.05.2021[A several-week history of inflammatory changes in the right foot and right hand of a 57-year-old male patient]
18.05.2021Internist (Berl) 2021; 62:555-561
von Lucadou M, Strahm Carol, Potz S, Toepfer Andreas, Weber Markus, Passavanti Z, Neumann T
Challenges and opportunities for Multi-National Investigator-Initiated clinical trials for ALS: European and United States collaborations
Lingor P, Tostmann R, Neuwirth C, Meyer T, Lengenfeld T, Leha A, Kuttler J, Kollewe K, Kassubek J, Ilse B, Günther R, Ahmed R, Langbein T, Wuu J, Hennecke C, Hussain S, Statland J, Koch J, Benatar M. Challenges and opportunities for Multi-National Investigator-Initiated clinical trials for ALS: European and United States collaborations. Amyotroph Lateral Scler Frontotemporal Degener 2021; 22:419-425.
03.02.2021Challenges and opportunities for Multi-National Investigator-Initiated clinical trials for ALS: European and United States collaborations
03.02.2021Amyotroph Lateral Scler Frontotemporal Degener 2021; 22:419-425
Lingor Paul, Tostmann Ralf, Neuwirth Christoph, Meyer Thomas, Lengenfeld Teresa, Leha Andreas, Kuttler Josua, Kollewe Katja, Kassubek Jan, Ilse Benjamin, Günther René, Ahmed Raees, Langbein Thomas, Wuu Joanne, Hennecke Christiane, Hussain Sumaira, Statland Jeffrey M, Koch Jan C, Benatar Michael
The Effect of SMN Gene Dosage on ALS Risk and Disease Severity.
Moisse M, Zwamborn R, Van Vugt J, van der Spek R, van Rheenen W, Kenna B, van Eijk K, Kenna K, Corcia P, Couratier P, Vourc'h P, Hardiman O, McLaughin R, Gotkine M, Drory V, Ticozzi N, Silani V, de Carvalho M, Mora J, Povedano M, Andersen P, Weber M, Başak N, Chen X, Eberle M, Al-Chalabi A, Shaw C, Openshaw P, Morrison K, Landers J, Glass J, Robberecht W, van Es M, Van den Berg L, Veldink J, Van Damme P, Project MinE Sequencing Consortium. The Effect of SMN Gene Dosage on ALS Risk and Disease Severity. Ann Neurol 2021; 89:686-697.
15.01.2021The Effect of SMN Gene Dosage on ALS Risk and Disease Severity.
15.01.2021Ann Neurol 2021; 89:686-697
Moisse Matthieu, Zwamborn Ramona A J, Van Vugt Joke J F A, van der Spek Rick, van Rheenen Wouter, Kenna Brendan, van Eijk Kristel R, Kenna Kevin P, Corcia Philippe, Couratier Philippe, Vourc'h Patrick, Hardiman Orla, McLaughin Russell, Gotkine Marc, Drory Vivian E, Ticozzi Nicola, Silani Vincenzo, de Carvalho Mamede, Mora Jesus S, Povedano Monica, Andersen Peter Munch, Weber Markus, Başak Nazli A, Chen Xiao, Eberle Michael A, Al-Chalabi Ammar, Shaw Christopher E, Openshaw Peter J M, Morrison Karen E, Landers John E, Glass Jonathan D, Robberecht Wim, van Es Michael, Van den Berg Leonard, Veldink Jan H, Van Damme Philip, Project MinE Sequencing Consortium
Seit mehreren Wochen bestehende entzündliche Veränderungen an rechtem Fuß und rechter Hand bei einem 57-jährigen Patienten
Neumann T, Lucadou M, Strahm C, Potz S, Toepfer M, Weber M, Passavanti Z. Seit mehreren Wochen bestehende entzündliche Veränderungen an rechtem Fuß und rechter Hand bei einem 57-jährigen Patienten. Internist 2020
18.12.2020Seit mehreren Wochen bestehende entzündliche Veränderungen an rechtem Fuß und rechter Hand bei einem 57-jährigen Patienten
18.12.2020Internist 2020
Neumann Thomas, Lucadou M, Strahm Carol, Potz S, Toepfer M, Weber Markus, Passavanti Z
MUNIX in children with spinal muscular atrophy: An unexpected journey
Neuwirth C, Weber M. MUNIX in children with spinal muscular atrophy: An unexpected journey. Muscle Nerve 2020; 62:565-566.
11.09.2020MUNIX in children with spinal muscular atrophy: An unexpected journey
11.09.2020Muscle Nerve 2020; 62:565-566
Neuwirth Christoph, Weber Markus
Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
Haider A, Pacher P, Herde A, Spinelli F, Ahmed H, Atz K, Keller C, Weber M, Schibli R, Mu L, Grether U, Knuesel I, Bartelmus C, Gobbi L, Kretz J, Ullmer C, Brink A, Honer M, Woltering T, Muri D, Iding H, Bürkler M, Binder M, Ametamey S. Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors. J Med Chem 2020; 63:10287-10306.
01.09.2020Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors
01.09.2020J Med Chem 2020; 63:10287-10306
Haider Ahmed, Pacher Pal, Herde Adrienne Müller, Spinelli Francesco, Ahmed Hazem, Atz Kenneth, Keller Claudia, Weber Markus, Schibli Roger, Mu Linjing, Grether Uwe, Knuesel Irene, Bartelmus Christian, Gobbi Luca, Kretz Julian, Ullmer Christoph, Brink Andreas, Honer Michael, Woltering Thomas J, Muri Dieter, Iding Hans, Bürkler Markus, Binder Martin, Ametamey Simon M
TRICALS: creating a highway toward a cure
van Eijk R, Hardiman O, Al-Chalabi A, van Es M, Reviers E, Povedano M, Corcia P, Ingre C, Weber M, Chio A, Van Damme P, Roes K, McDermott C, Kliest T, van den Berg L. TRICALS: creating a highway toward a cure. Amyotroph Lateral Scler Frontotemporal Degener 2020; 21:496-501.
09.07.2020TRICALS: creating a highway toward a cure
09.07.2020Amyotroph Lateral Scler Frontotemporal Degener 2020; 21:496-501
van Eijk Ruben P A, Hardiman Orla, Al-Chalabi Ammar, van Es Michael A, Reviers Evy, Povedano Monica, Corcia Philippe, Ingre Caroline, Weber Markus, Chio Adriano, Van Damme Philip, Roes Kit C B, McDermott Christopher J, Kliest Tessa, van den Berg Leonard H
Measuring Outcomes in Adults with Spinal Muscular Atrophy - Challenges and Future Directions - Meeting Report
Sansone V, Kleinschnitz C, Vazquez-Costa J, Neuwirth C, Lochmüller H, Mercuri E, Delstanche S, Attarian S, Walter M, Hagenacker T. Measuring Outcomes in Adults with Spinal Muscular Atrophy - Challenges and Future Directions - Meeting Report. J Neuromuscul Dis 2020
12.06.2020Measuring Outcomes in Adults with Spinal Muscular Atrophy - Challenges and Future Directions - Meeting Report
12.06.2020J Neuromuscul Dis 2020
Sansone V A, Kleinschnitz C, Vazquez-Costa J F, Neuwirth Christoph, Lochmüller H, Mercuri E, Delstanche S, Attarian S, Walter M C, Hagenacker T
Estimating the Number of Motor Neurons: First Go to the Roots Before Cropping the Fruits
Neuwirth C, Weber M. Estimating the Number of Motor Neurons: First Go to the Roots Before Cropping the Fruits. Muscle Nerve 2020; 62:154-155.
29.05.2020Estimating the Number of Motor Neurons: First Go to the Roots Before Cropping the Fruits
29.05.2020Muscle Nerve 2020; 62:154-155
Neuwirth Christoph, Weber Markus
Nine Hole Peg Test and Transcranial Magnetic Stimulation: Useful to Evaluate Dexterity of the Hand and Disease Progression in Amyotrophic Lateral Sclerosis
Czell D, Neuwirth C, Weber M, Sartoretti-Schefer S, Gutzeit A, Reischauer C. Nine Hole Peg Test and Transcranial Magnetic Stimulation: Useful to Evaluate Dexterity of the Hand and Disease Progression in Amyotrophic Lateral Sclerosis. Neurol Res Int 2019; 2019:7397491.
07.11.2019Nine Hole Peg Test and Transcranial Magnetic Stimulation: Useful to Evaluate Dexterity of the Hand and Disease Progression in Amyotrophic Lateral Sclerosis
07.11.2019Neurol Res Int 2019; 2019:7397491
Czell David, Neuwirth Christoph, Weber Markus, Sartoretti-Schefer Sabine, Gutzeit Andreas, Reischauer Carolin
Poly-glycine-alanine exacerbates C9orf72 repeat expansion-mediated DNA damage via sequestration of phosphorylated ATM and loss of nuclear hnRNPA3
Nihei Y, Edbauer D, Nuscher B, Kamp F, Bavarian Brain Banking Alliance, German Consortium for Frontotemporal Lobar Degeneration, Weber M, Sommacal A, Hermann A, Japtok J, Khosravi B, Zhou Q, Arzberger T, Werner G, Mori K, Haass C. Poly-glycine-alanine exacerbates C9orf72 repeat expansion-mediated DNA damage via sequestration of phosphorylated ATM and loss of nuclear hnRNPA3. Acta Neuropathol 2019; 139:99-118.
23.10.2019Poly-glycine-alanine exacerbates C9orf72 repeat expansion-mediated DNA damage via sequestration of phosphorylated ATM and loss of nuclear hnRNPA3
23.10.2019Acta Neuropathol 2019; 139:99-118
Nihei Yoshihiro, Edbauer Dieter, Nuscher Brigitte, Kamp Frits, Bavarian Brain Banking Alliance, German Consortium for Frontotemporal Lobar Degeneration, Weber Markus, Sommacal Andreas, Hermann Andreas, Japtok Julia, Khosravi Barham, Zhou Qihui, Arzberger Thomas, Werner Georg, Mori Kohji, Haass Christian
The revised El Escorial criteria "clinically probable laboratory supported ALS"-once a promising now a superfluous category?
Braun N, Macklin E, Sinani E, Sherman A, Weber M, Pooled Resource Open-Access ALS Clinical Trials Consortium. The revised El Escorial criteria "clinically probable laboratory supported ALS"-once a promising now a superfluous category?. Amyotroph Lateral Scler Frontotemporal Degener 2019; 21:24-28.
27.09.2019The revised El Escorial criteria "clinically probable laboratory supported ALS"-once a promising now a superfluous category?
27.09.2019Amyotroph Lateral Scler Frontotemporal Degener 2019; 21:24-28
Braun Nathalie, Macklin Eric A, Sinani Ervin, Sherman Alexander, Weber Markus, Pooled Resource Open-Access ALS Clinical Trials Consortium
The revised El Escorial criteria “clinically probable laboratory supported ALS”—once a promising now a superfluous category?
Braun N. The revised El Escorial criteria “clinically probable laboratory supported ALS”—once a promising now a superfluous category?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2019
26.09.2019The revised El Escorial criteria “clinically probable laboratory supported ALS”—once a promising now a superfluous category?
26.09.2019Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2019
Braun Nathalie
An overview of motor unit number index reproducibility in amyotrophic lateral sclerosis
Fathi D, Nafissi S, Attarian S, Neuwirth C, Fatehi F. An overview of motor unit number index reproducibility in amyotrophic lateral sclerosis. Iran J Neurol 2019; 18:119-126.
06.07.2019An overview of motor unit number index reproducibility in amyotrophic lateral sclerosis
06.07.2019Iran J Neurol 2019; 18:119-126
Fathi Davood, Nafissi Shahriar, Attarian Shahram, Neuwirth Christoph, Fatehi Farzad
Standards for quantification of EMG and neurography
Stålberg E, Tankisi H, Sonoo M, Sanders D, Rutkove S, Rubin D, Podnar S, Pitt M, Neuwirth C, Kimura J, Falck B, van Dijk H, Zwarts M. Standards for quantification of EMG and neurography. Clin Neurophysiol 2019
10.06.2019Standards for quantification of EMG and neurography
10.06.2019Clin Neurophysiol 2019
Stålberg Erik, Tankisi Hatice, Sonoo Masahiro, Sanders Donald B, Rutkove Seward, Rubin Devon I, Podnar Simon, Pitt Matthew, Neuwirth Christoph, Kimura Jun, Falck Björn, van Dijk Hans, Zwarts Machiel
Misfolded SOD1 inclusions in patients with mutations in and other ALS/FTD-associated genes
Forsberg K, Graffmo K, Pakkenberg B, Weber M, Nielsen M, Marklund S, Brännström T, Andersen P. Misfolded SOD1 inclusions in patients with mutations in and other ALS/FTD-associated genes. J Neurol Neurosurg Psychiatry 2019; 90:861-869.
16.04.2019Misfolded SOD1 inclusions in patients with mutations in and other ALS/FTD-associated genes
16.04.2019J Neurol Neurosurg Psychiatry 2019; 90:861-869
Forsberg Karin, Graffmo Karin, Pakkenberg Bente, Weber Markus, Nielsen Martin, Marklund Stefan, Brännström Thomas, Andersen Peter Munch
ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis
Lingor P, Koch J, Ludolph A, Frontini R, Blankenstein C, Bidner H, Kuzma-Kozakiewicz M, Benatar M, Günther R, Neuwirth C, Leha A, Hilgers R, Friede T, Camu W, Weber M, ROCK-ALS Investigators. ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis. Front Neurol 2019; 10:293.
27.03.2019ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis
27.03.2019Front Neurol 2019; 10:293
Lingor Paul, Koch Jan C, Ludolph Albert, Frontini Roberto, Blankenstein Christiane, Bidner Helen, Kuzma-Kozakiewicz Magdalena, Benatar Michael, Günther René, Neuwirth Christoph, Leha Andreas, Hilgers Reinhard, Friede Tim, Camu William, Weber Markus, ROCK-ALS Investigators
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials
van den Berg L, McDermott C, Pioro E, Rosenfeld J, Silani V, Turner M, Weber M, Brooks B, Miller R, Mitsumoto H, Lomen-Hoerth C, Gubitz A, Genge A, Sorenson E, Gronseth G, Macklin E, Andrews J, Baloh R, Benatar M, Berry J, Chio A, Corcia P, Airlie House ALS Clinical Trials Guidelines Group. Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials. Neurology 2019; 92:e1610-e1623.
08.03.2019Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials
08.03.2019Neurology 2019; 92:e1610-e1623
van den Berg Leonard H, McDermott Christopher J, Pioro Erik P, Rosenfeld Jeffrey, Silani Vincenzo, Turner Martin R, Weber Markus, Brooks Benjamin Rix, Miller Robert G, Mitsumoto Hiroshi, Lomen-Hoerth Catherine, Gubitz Amelie K, Genge Angela, Sorenson Eric, Gronseth Gary, Macklin Eric A, Andrews Jinsy, Baloh Robert H, Benatar Michael, Berry James D, Chio Adriano, Corcia Philippe, Airlie House ALS Clinical Trials Guidelines Group
Assessment of the reliability of the motor unit size index (MUSIX) in single subject "round-robin" and multi-centre settings
Alix J, Nandedkar S, Stålberg E, Barkhaus P, Furtula J, van Dijk J, Baldinger R, Costa J, Otto M, Sandberg A, Schrooten M, Omer T, Moglia C, Neuwirth C, Gelder L, Burkhardt C, Castro J, de Carvalho M, Gawel M, Goedee S, Grosskreutz J, Lenglet T, Weber M. Assessment of the reliability of the motor unit size index (MUSIX) in single subject "round-robin" and multi-centre settings. Clin Neurophysiol 2019; 130:666-674.
21.02.2019Assessment of the reliability of the motor unit size index (MUSIX) in single subject "round-robin" and multi-centre settings
21.02.2019Clin Neurophysiol 2019; 130:666-674
Alix James J P, Nandedkar Sanjeev, Stålberg Erik, Barkhaus Paul E, Furtula Jasna, van Dijk Johannes P, Baldinger Reto, Costa João, Otto Marit, Sandberg Arne, Schrooten Maarten, Omer Taha, Moglia Cristina, Neuwirth Christoph, Gelder Lucy, Burkhardt Christian, Castro José, de Carvalho Mamede, Gawel Malgorzata, Goedee Stephan, Grosskreutz Julian, Lenglet Timothée, Weber Markus